A portable device for accurate hemoglobin A1C testing
Portable, affordable, quantitative microchip electrophoresis for hemoglobin A1C testing
This study is working on a small, easy-to-use device called HemeChip that can quickly and affordably check hemoglobin A1C levels for people with diabetes, especially in places where healthcare is hard to reach, so they can better manage their condition.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Hemex Health, INC. NIH-funded |
| Lab location | 1 site (Portland, UNITED STATES) |
| Project ID | NIH-10656550 on NIH RePORTER |
What this research studies
This research focuses on developing a portable and affordable microchip electrophoresis system for testing hemoglobin A1C levels, which is crucial for managing diabetes. The device, known as HemeChip, aims to provide accurate results even in areas with limited access to healthcare facilities. By improving the reliability of A1C testing, especially in low and middle-income countries, the research seeks to enhance diabetes management and patient outcomes. The approach involves using advanced technology to ensure that patients can receive timely and precise testing without the need for expensive laboratory services.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with diabetes, particularly in low and middle-income countries where access to reliable testing is limited.
Not a fit: Patients who do not have diabetes or prediabetes may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve diabetes management by providing accessible and accurate hemoglobin A1C testing.
How similar studies have performed: Other research has shown success with portable diagnostic devices, indicating a promising potential for this novel approach.
Where this research is happening
Portland, UNITED STATES
- Hemex Health, INC. — Portland, United States (Active)
Researchers
- Principal investigator: Galen, Peter — Hemex Health, INC.
- Study coordinator: Galen, Peter
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.